Statute Details
- Title: Health Products (Medical Devices) Regulations 2010
- Act Code: HPA2007-S436-2010
- Type: Subsidiary legislation (SL)
- Current status (as provided): Current version as at 27 Mar 2026
- Enacting Act (context): Made under the Health Products Act (HPA) framework
- Key commencement/citation provision: Part I, regulation 1 (citation and commencement)
- Key definitions provision: Part I, regulation 2
- Major subject areas (by Parts): Manufacture/import licensing; supply and exceptions; emergency devices; presentation and advertising controls; registration and evaluation; certificates for export; duties/obligations and enforcement; records, reporting, recalls; miscellaneous provisions
- Notable schedules: Second Schedule (diseases/conditions for advertising restrictions); Third Schedule (assignment into classes); Fifth Schedule (implantable medical devices)
What Is This Legislation About?
The Health Products (Medical Devices) Regulations 2010 (“Medical Devices Regulations”) is Singapore’s regulatory framework for controlling medical devices across their lifecycle—especially manufacture, import, supply, presentation, advertising, registration, and post-market safety monitoring. In plain terms, it sets rules to ensure that medical devices placed on the market are properly authorised (where required), correctly classified, accurately represented to users, and supported by safety and performance obligations.
The Regulations sit within a wider health-product regulatory architecture under the Health Products Act. They operationalise how the Health Sciences Authority (the “Authority”) regulates medical devices, including licensing for manufacturers/importers/wholesalers, registration of devices (including evaluation processes), and compliance duties such as record-keeping, defect/adverse event reporting, and recall/field safety corrective action notifications.
Practically, the Regulations are designed to manage risk. They distinguish between device classes (including “Class A” devices) and between different user contexts (e.g., “professional use only” and “trained user only” devices). They also create targeted exceptions for activities that would otherwise be caught by licensing/registration requirements—such as custom-made devices, maintenance/repair, export, non-clinical use, and certain clinical research activities.
What Are the Key Provisions?
1) Licensing and authorisation for manufacture and import (Part IA and Part II). The Regulations introduce licensing requirements for manufacturers and importers. Part IA contains provisions on the “requirements for issue of manufacturer’s licence” (regulation 2A) and “requirements for issue of importer’s licence” (regulation 2B). While the extract does not reproduce the full text of these licensing criteria, the structure indicates that the Authority must be satisfied as to matters such as suitability, compliance systems, and conditions necessary to ensure safe and lawful handling of medical devices.
Part II then addresses manufacture and import “without licence” through a set of specific allowances and conditions. For example, regulation 3 covers manufacture of medical devices, while regulations 3A–3D carve out particular categories: manufacture for clinical research (3A), laboratory-developed tests (3B), Class A medical devices for charitable purposes (3C), and specified dental medical devices (3D). Importantly, the Regulations also address import scenarios such as personal use (4A), devices licensed under the Radiation Protection Act (4B), and import for clinical research (4C). This indicates a risk-based approach: not every activity requires the same level of authorisation, but the law still regulates the circumstances under which exceptions apply.
2) Supply and wholesaling controls, including unregistered-device exceptions (Part III). Part III governs supply of medical devices. Division 1 addresses wholesale supply, including requirements for issue of a wholesaler’s licence (regulation 4D). It also provides for wholesaling of self-manufactured devices (regulation 5) and wholesaling of devices licensed under the Radiation Protection Act (5A) or for clinical research (5B). This is significant for supply-chain compliance: a company’s role (manufacturer vs importer vs wholesaler vs supplier) affects which authorisations and duties attach.
Division 2 then addresses “unregistered medical devices” and provides exceptions. The extract lists multiple exceptions, including: custom-made devices (regulation 6); devices after maintenance or repair (7); devices for patients’ use (8); export or re-export (9); non-clinical use (10); clinical research (10A); and Class A medical devices (10B). There are also “phased implementation” exceptions (regulation 11), suggesting that the prohibition or registration requirement may have been introduced gradually or modified over time.
Division 2A provides further exceptions, such as import by a licensed manufacturer without an importer’s licence (11A), wholesale to ships or aircraft by a licensed importer without a wholesaler’s licence (11B), and “previously registered medical devices” (11C). These provisions are particularly relevant for practitioners advising on cross-border logistics, humanitarian/charitable supply, and transitional compliance.
3) Requirements for supply by device type and user restrictions (Division 3). Division 3 sets requirements for supply. It includes regulation 12 (supply of Class A medical devices), regulation 13 (supply of “professional use only” medical devices), regulation 13A (supply for clinical research), and regulation 13B (supply of “trained user only” medical devices). The legal significance is that the Regulations do not treat all devices as interchangeable: the law requires that devices restricted to certain users are supplied only in the appropriate manner, likely including restrictions on distribution channels and information provided to ensure correct use.
4) Emergency medical devices exception (Part IIIA). Regulation 13C creates an exception for “emergency medical devices” covering manufacture, import, and supply. While the extract does not detail the conditions, the presence of a dedicated emergency regime indicates that the Authority recognises time-critical public health needs. For counsel, this is a key area to assess whether an urgent procurement or deployment can rely on the emergency exception and what documentation or safeguards are required.
5) Presentation and advertising controls (Parts IV and V). Parts IV and V regulate how medical devices are presented and advertised. Part IV includes provisions on trade descriptions (regulation 14), information to be provided with medical devices (15), general labelling provisions (16), and substantiation of claims about uniqueness and prominence (17). It also provides corrective measures where trade descriptions contravene the law (18). Part V similarly regulates advertisements: advertisement of a medical device (19), substantiation of uniqueness/prominence claims in advertisements (20), and restrictions on advertising “professional use only” devices (21). Critically, regulation 22 restricts advertisements promoting medical devices for specified diseases and conditions, with the Second Schedule listing the relevant diseases/conditions. Regulation 23 gives the Authority power to require copies of advertisements, supporting enforcement and monitoring.
6) Registration of medical devices and evaluation (Part VI). Part VI is central to market access. It includes: assignment of devices into classes (regulation 24); requirements for registration (25); evaluation process (26); and a specific provision on cancellation of registration for non-payment of a retention fee within a prescribed time (26A). Regulation 27 addresses disclosure of information on applications for registration. For practitioners, these provisions govern when and how a device must be registered, how the Authority evaluates submissions, and what happens if fees are not paid—affecting ongoing compliance and the legality of continued supply.
7) Certificates for export (Part VII). Part VII includes regulation 30 on certification of medical devices intended for export. This is important for manufacturers and exporters seeking to demonstrate regulatory status to foreign regulators or counterparties. The extract notes that regulations 27–29 are deleted, indicating that the certificate regime has been streamlined over time.
8) Duties and obligations, records, reporting, and enforcement (Part VIII). Part VIII imposes ongoing compliance duties on licensees, suppliers, registrants, and other stakeholders. The extract highlights: duties to comply with enforcement orders (31); duties to comply with licence/registration conditions (32); and specific duties for manufacturers (33), importers (34), and wholesalers (35). It also includes a duty for suppliers of unregistered Class A devices to furnish information (35A) and a duty for registrants to ensure compliance with safety and performance requirements (36). There are also duties for sponsors and related parties (36A).
Enforcement is supported by an offence provision for contravention of duties (37). The Regulations then require extensive record-keeping: records of manufacture (38), records of supply (39), and additional clinical research records (39A and 39B). For implantable medical devices, qualified practitioners must maintain records (40). There are duties to maintain records of complaints (41) and to report defects and adverse effects (42), report information adversely affecting quality/safety/efficacy (43), and notify the Authority concerning recall (44) and field safety corrective action (46–47). Finally, the Regulations address changes affecting licences (48) and changes concerning registered medical devices (49). These provisions are critical for post-market surveillance and for responding to safety signals.
How Is This Legislation Structured?
The Regulations are organised into Parts that track the medical device value chain and regulatory lifecycle:
Part I (Preliminary) contains citation/commencement and definitions.
Part IA sets licensing requirements for manufacturers and importers.
Part II provides circumstances where manufacture/import can occur without a licence (including clinical research and specific categories like Class A charitable purposes and specified dental devices).
Part III regulates supply, with Divisions covering wholesale supply (licensing and permitted wholesaling) and exceptions for unregistered devices, followed by requirements for supply based on device class and user restrictions.
Part IIIA creates a dedicated emergency medical devices exception.
Parts IV and V regulate presentation (trade descriptions, labelling, required information, substantiation) and advertising (including restrictions for certain devices and disease/condition advertising limits).
Part VI governs registration, classification, evaluation, and fee-related cancellation.
Part VII addresses export certification.
Part VIII imposes duties and obligations, including record-keeping, complaint handling, defect/adverse event reporting, recall and field safety corrective action notifications, and change management.
Part X (Miscellaneous) includes notices to the Authority, confidentiality, revocation, and savings/transitional provisions.
Who Does This Legislation Apply To?
The Regulations apply to persons and entities involved in the manufacture, import, wholesale supply, and supply of medical devices in Singapore, as well as those responsible for registration and post-market obligations. This includes licensed manufacturers, licensed importers, licensed wholesalers, registrants, suppliers (including those dealing with unregistered Class A devices under exceptions), and qualified practitioners who must maintain records for implantable devices.
They also apply to advertising and presentation activities. Accordingly, marketing authorisations, product claims, and promotional materials must comply with the trade description, labelling, substantiation, and advertising restriction provisions. Clinical research sponsors and related parties are also within scope through specific duties and exceptions for clinical research manufacture/import/supply.
Why Is This Legislation Important?
For practitioners, the Medical Devices Regulations are important because they translate the Health Products regulatory framework into operational compliance obligations. They determine whether a device can be manufactured/imported/supplied lawfully, whether it must be registered, and what conditions apply to different device classes and user restrictions.
The Regulations also have practical enforcement consequences. Non-compliance can trigger offences (Part VIII) and administrative actions such as cancellation of registration for non-payment of retention fees (26A). More broadly, the record-keeping and reporting duties (complaints, defects, adverse effects, recall and field safety corrective action) create a compliance infrastructure that supports investigations and risk management. Companies that cannot produce records or demonstrate appropriate reporting may face regulatory action and reputational harm.
Finally, the advertising and presentation controls (Parts IV and V) are often a litigation and enforcement flashpoint. The substantiation requirements for uniqueness/prominence claims and the restrictions on advertising for specified diseases/conditions mean that marketing teams must coordinate closely with regulatory and clinical evidence holders. The Authority’s power to require copies of advertisements (23) further underscores that promotional compliance is not merely “best practice” but a legal requirement.
Related Legislation
- Health Products Act (enabling framework for health product regulation, including medical devices)
- Healthcare Services Act 2020
- Human Biomedical Research Act 2015 (relevant to clinical research contexts)
- Dental Registration Act 1999 (relevant to specified dental medical devices and practitioner contexts)
- Radiation Protection Act (referenced indirectly through devices licensed under that Act)
Source Documents
This article provides an overview of the Health Products (Medical Devices) Regulations 2010 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.